Abstract
Aspergillus causes a range of diseases in patients with immunodeficiency or underlying pulmonary diseases. Aspergillus-specific immunoglobulin G antibody (Asp-IgG) is produced in response to Aspergillus pathopoiesis. Currently, Asp-IgG is included in the diagnostic criteria for chronic pulmonary aspergillosis (CPA) and allergic bronchopulmonary aspergillosis (ABPA). In recent years, some researches have proved that Asp-IgG also has important diagnostic value for non-neutropenic patients with invasive pulmonary aspergillosis (IPA). This review summarized the progress of Asp-IgG in the management of different types of pulmonary aspergillosis, and the advantages of rapid detection methods for Asp-IgG.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
